Compounded versus brand-name semaglutide: expiration differences that matter The distinction between compounded and brand-name semaglutide becomes especially important when discussing expiration

Several important safety considerations from UK SmPCs include: Pancreatitis risk : Seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Diabetic retinopathy complications : Particularly with semaglutide in those with pre-existing retinopathy Dehydration and acute kidney injury : Possible with severe gastrointestinal side effects Hypoglycaemia : Increased risk when used with insulin or sulfonylureas (dose adjustment of these medications may be needed) Pregnancy/breastfeeding : Weight management GLP-1 agonists (Wegovy, Saxenda) are contraindicated in pregnancy and should be avoided during breastfeeding [5] [2] Regarding mental health specifically, regulatory agencies have scrutinised GLP-1 medications for potential psychiatric adverse effects
By 8 to 12 weeks, skin and recovery markers are easier to evaluate consistently
But it wasnt until semaglutide hit the market (first as Ozempic [archived link] in 2017 followed by Wegovy [archived link]) in 2021) that GLP-1 RAs captured the worlds attention
Berning P, Adhikari R, Schroer AE, Jelwan YA, Razavi AC, Blaha MJ, et al
Experience the confidence that comes with glowing, healthy skin